Cargando…

Where to Initiate Basal Insulin Therapy: Inpatient or Outpatient Department? Real-World Observation in China

BACKGROUND: This study aims to compare the effectiveness of initiating insulin therapy in inpatient and outpatient settings during a 6-month follow-up period among patients with type 2 diabetes mellitus (T2DM) in real-world settings. MATERIALS AND METHODS: The study was based on the ORBIT study, a r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Minyuan, Zhang, Puhong, Zhao, Yang, Duolikun, Nadila, Ji, Linong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635311/ https://www.ncbi.nlm.nih.gov/pubmed/36341227 http://dx.doi.org/10.2147/DMSO.S386230

Ejemplares similares

Effectiveness and safety of basal insulin therapy in type 2 diabetes mellitus patients with or without metformin observed in a national cohort in China
por: Zhang, Puhong, et al.
Publicado: (2022)

Changes of health-related quality of life after initiating basal insulin treatment among people with type 2 diabetes
por: Zhang, Puhong, et al.
Publicado: (2023)

Factors and outcomes associated with discontinuation of basal insulin therapy in patients with type 2 diabetes mellitus
por: Zhang, Puhong, et al.
Publicado: (2020)

Road to Hierarchical Diabetes Management at Primary Care (ROADMAP) Study in China: Protocol for the Statistical Analysis of a Cluster Randomized Controlled Trial
por: Li, Xian, et al.
Publicado: (2020)

Glycemic Control Following GLP-1 RA or Basal Insulin Initiation in Real-World Practice: A Retrospective, Observational, Longitudinal Cohort Study
por: Peng, Xuejun Victor, et al.
Publicado: (2020)

Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): A cluster randomized trial
por: Jia, Weiping, et al.
Publicado: (2021)

Study protocol for the road to hierarchical diabetes management at primary care (ROADMAP) study in China: a cluster randomised controlled trial
por: Jia, Weiping, et al.
Publicado: (2020)

First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in Asia
por: TSAI, Shih-Tzer, et al.
Publicado: (2011)

A Pragmatic Study of Basal and Mid-Mixture Insulins as Starter Insulins in Chinese Patients With Type 2 Diabetes: Observations From Long-Term, Real-World Experience
por: Zeng, Tianshu, et al.
Publicado: (2021)

A Real-World, Observational Study of the Initiation, Use, and Effectiveness of Basal-Bolus or Premixed Insulin in Japanese People with Type 2 Diabetes
por: Miyoshi, Hideaki, et al.
Publicado: (2021)

A pragmatic study of mid‐mixture insulin and basal insulin treatment in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic medications: A lesson from real‐world experience
por: Zhang, Xiaomei, et al.
Publicado: (2020)

Medical costs and out-of-pocket expenditures associated with multimorbidity in China: quantile regression analysis
por: Zhao, Yang, et al.
Publicado: (2021)

Comparison of the Effect of Glycemic Control in Type 2 Diabetes Outpatients Treated With Premixed and Basal Insulin Monotherapy in China
por: Liu, Guangxu, et al.
Publicado: (2018)

The basal to total insulin ratio in outpatients with diabetes on basal-bolus regimen
por: Castellano, Elena, et al.
Publicado: (2018)

Initiation of iGlarLixi Versus Basal-Bolus Insulin in Adults With Type 2 Diabetes Advancing From Basal Insulin Therapy: The SoliComplex Real-World Study
por: Pantalone, Kevin M., et al.
Publicado: (2023)

Correction to: The basal to total insulin ratio in outpatients with diabetes on basal-bolus regimen
por: Castellano, Elena, et al.
Publicado: (2018)

Basal-bolus insulin therapy in postoperative inpatients with diabetes mellitus: directions for future quality-improvement initiatives
por: Cook, Curtiss B, et al.
Publicado: (2017)

Inpatient and Outpatient Technologies to Assist in the Management of Insulin Dosing
por: Cui, Ling, et al.
Publicado: (2020)

Use of Linagliptin for the Management of Medicine Department Inpatients with Type 2 Diabetes in Real-World Clinical Practice (Lina-Real-World Study)
por: Pérez-Belmonte, Luis M., et al.
Publicado: (2018)

Real-World Effectiveness of Insulin Glargine 300 Initiation in Switzerland
por: Thomann, Robert, et al.
Publicado: (2020)

Intensification of Basal Insulin Therapy with Lixisenatide in Patients with Type 2 Diabetes in a Real-World Setting: The BASAL-LIXI Study
por: Bellido, Diego, et al.
Publicado: (2018)

A real‐world, observational study of weekly exenatide added to basal insulin in patients with type 2 diabetes mellitus (NCT02895672)
por: Stryker, Matthew D., et al.
Publicado: (2017)

Prevalence of Albuminuria in Cardiology and Endocrinology Departments and Its Influencing Factors: A Multicenter, Real-World Evidence Study in China
por: Ren, Qian, et al.
Publicado: (2020)

Switching Patients with Type 1 Diabetes to Insulin Degludec from Other Basal Insulins: Real-World Data of Effectiveness and Safety
por: Ponzani, Paola, et al.
Publicado: (2019)

Observable Effects of Atmospheric Pollution on Outpatient and Inpatient Morbidity in Bulgaria
por: PLATIKANOVA, Magdalena, et al.
Publicado: (2016)

Covid-19 in outpatient and inpatient Asthmatics in Lebanon: Real-life experience
por: Irani, Carla, et al.
Publicado: (2022)

On the 'Where' and 'When' of Eye Guidance in Real-World Scenes
por: Nuthmann, Antje
Publicado: (2019)

Real‐world evidence concerning clinical and economic outcomes of switching to insulin glargine 300 units/mL vs other basal insulins in patients with type 2 diabetes using basal insulin
por: Zhou, Fang Liz, et al.
Publicado: (2018)

Real‐world evidence of the effectiveness on glycaemic control of early simultaneous versus later sequential initiation of basal insulin and glucagon‐like peptide‐1 receptor agonists
por: Rosenstock, Julio, et al.
Publicado: (2020)

Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA
por: Blonde, Lawrence, et al.
Publicado: (2018)

The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real‐world setting
por: Meneghini, Luigi F., et al.
Publicado: (2019)

iGlarLixi versus basal plus Rapid‐Acting insulin in adults with type 2 diabetes advancing from basal insulin therapy: The SoliSimplify Real‐World study
por: McCrimmon, Rory J., et al.
Publicado: (2022)

The prevalence of multimorbidity and its association with physical activity and sleep duration in middle aged and elderly adults: a longitudinal analysis from China
por: He, Li, et al.
Publicado: (2021)

Case Study: Remission of Type 2 Diabetes After Outpatient Basal Insulin Therapy
por: Schmidt, Sierra C., et al.
Publicado: (2016)

Impact of Outpatient vs Inpatient ABSSSI Treatment on Outcomes: A Retrospective Observational Analysis of Medical Charts Across US Emergency Departments
por: Bookstaver, P Brandon, et al.
Publicado: (2018)

The importance of the initial period of basal insulin titration in people with diabetes
por: Khunti, Kamlesh, et al.
Publicado: (2020)

A 1‐year, prospective, observational study of Japanese outpatients with type 1 and type 2 diabetes switching from insulin glargine or detemir to insulin degludec in basal–bolus insulin therapy (Kumamoto Insulin Degludec Observational study)
por: Shimoda, Seiya, et al.
Publicado: (2016)

Real-World Functioning in Psychiatric Outpatients: Predictive Factors
por: Bozzatello, Paola, et al.
Publicado: (2022)

An Overview of Outpatient and Inpatient Detoxification
por: Hayashida, Motoi
Publicado: (1998)

Clinical and economic outcomes among injection-naïve patients with type 2 diabetes initiating dulaglutide compared with basal insulin in a US real-world setting: the DISPEL Study
por: Mody, Reema, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_or86gqqfqfikd4o1331dnd3887